Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 18/20 | 0.52 |
| ▸ | CNR2 | P34972 | 11/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1900604 | 0.83 | CNR1 (0.77) | CNR1CNR2CYP2D6CYP2C9KCNH2 | |
| SCHEMBL2246652 | 0.75 | CNR1 (0.62) | CNR1CNR2CYP2D6CYP2C9KCNH2 | |
| SCHEMBL1829124 | 0.72 | CNR1 (0.76) | CNR1CNR2CYP2D6CYP2C9KCNH2 | |
| SCHEMBL3524162 | 0.71 | CNR1 (0.60) | CNR1CNR2FDFT1 | |
| SCHEMBL6515732 | 0.71 | CNR1 (0.55) | CNR1CNR2 | |
| SCHEMBL3079318 | 0.69 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL1898233 | 0.69 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL13894033 | 0.69 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL13114227 | 0.69 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL3525559 | 0.68 | FDFT1 (0.59) | CNR1CNR2FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2001472-A2 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | Merck and Co., Inc. (US) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007111864-A2 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | MERCK & CO., INC. (US) | 2007-10-04 | — | — | WO | disclosed |